Trial · NCT02777385
Adverse events722
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 722
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 32 | 41 | |
| other | Anemia | Blood and lymphatic system disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 34 | 39 | |
| other | Blood and lymphatic system disorders - Other, specifygranulomatous lymphadenitis | Blood and lymphatic system disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 0 | 41 | |
| other | Blood and lymphatic system disorders - Other, specifygranulomatous lymphadenitis | Blood and lymphatic system disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 1 | 39 | |
| other | Blood and lymphatic system disorders - Other, specifyvenous thrombosis | Blood and lymphatic system disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 1 | 41 | |
| other | Blood and lymphatic system disorders - Other, specifyvenous thrombosis | Blood and lymphatic system disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 0 | 39 | |
| other | Acute coronary syndrome | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 0 | 41 | |
| other | Acute coronary syndrome | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 1 | 39 | |
| other | Aortic valve disease | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 0 | 41 | |
| other | Aortic valve disease | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 1 | 39 | |
| other | Atrial fibrillation | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 1 | 41 | |
| other | Atrial fibrillation | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 0 | 39 | |
| other | Cardiac disorders - Other, specify | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 0 | 41 | |
| other | Cardiac disorders - Other, specify | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 1 | 39 | |
| other | Cardiac disorders - Other, specifyBradycardia | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 1 | 41 | |
| other | Cardiac disorders - Other, specifyBradycardia | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 0 | 39 | |
| other | Cardiac disorders - Other, specifyCAD | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 1 | 41 | |
| other | Cardiac disorders - Other, specifyCAD | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 0 | 39 | |
| other | Cardiac disorders - Other, specifyCoronary artery calcifications | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Concurrent | 1 | 41 | |
| other | Cardiac disorders - Other, specifyCoronary artery calcifications | Cardiac disorders | Cisplatin + Radiation + Pembrolizumab - Sequential | 0 | 39 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02777385/events